Skip to main content

Dri Healthcare Trust(DHT-UN-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Dri Healthcare Trust down on Thursday (DHT-UN)

Automated Summaries - The Globe and Mail - Thu Apr 18, 4:02PM CDT

Today during trading, shares of Dri Healthcare Trust opened at $16.90 and closed at $16.97. Intraday prices ranged from $16.78 to $17.17.

Share prices dipped -0.18% from the previous day's close of $17.00.

Today across North America, the TSX Composite closed tsx_percentage_change% at 21708.44, the S&P 500 closed sp_500_percentage_change% at 5022.21, the Dow Jones Industrial Average closed dow_jones_percentage_change% at 37753.31 and the Nasdaq Composite closed nasdaq_percentage_change% at 15683.37.

Dri Healthcare Trust traded under DHT-UN on the Toronto Stock Exchange (TSX).

A total of 46,583 shares was traded during the session, with total trades of 95, while having an average volume of 31,630 over 5 days.

Trading across the entire TSX saw 2,663 price advancers against 2,504 declines and 146 unchanged.

During the prior 52 weeks, DHT-UN.TO has traded as high as $17.43 (April 15,2024) and low as $7.55 (April 24,2023). Moreover, in the last 52 weeks, Dri Healthcare Trust's shares have risen 121.83 percent, while they have advanced 35.98% since the start of 2024.

Following today's trading, Dri Healthcare Trust has a market capitalization of $973.60 million on a float of 56,358 shares outstanding. Its annual EPS is $2.07.

Dri Healthcare Trust is a TSX Drug Specialty & Generic company headquartered in Toronto, CAN.

Currently, Dri Healthcare Trust has an average recommendation of "Strong Buy" based on 8.00 analysts according to Zacks. From those 8 analysts, 8 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe